Paul D. Larsen

A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors

Alexander Drilon, Ramamoorthy Nagasubramanian, James F. Blake et al. · Cancer Discovery · 2017 · 433 citations · Full text

Medicine, Oncology, Pharmacology +16

IL-Converting Enzyme/Caspase-1 Inhibitor VX-765 Blocks the Hypersensitive Response to an Inflammatory Stimulus in Monocytes from Familial Cold Autoinflammatory Syndrome Patients

Jeffrey H. Stack, Kevin Beaumont, Paul D. Larsen et al. · The Journal of Immunology · 2005 · 190 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Epstein‐Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis

Paul D. Larsen, Linda C. Bloomer, Patrick F. Bray · Neurology · 1985 · 139 citations

Life Sciences, Immunology, Neurology +14

Congenital lymphocytic choriomeningitis virus infection: spectrum of disease

Daniel J. Bonthius, R. Wright, Brian S. Tseng et al. · Annals of Neurology · 2007 · 128 citations

Medicine, Infectious Diseases, Pediatrics +17

XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases

Alexander M. Owyang, Hassan Issafras, John Corbin et al. · mAbs · 2011 · 89 citations · Full text

Pharmacy, Immunology, Pharmacology +17